Updated May 2026 · Verified against Natural Sciences and Engineering Research Council of Canada (NSERC) guidelines
Reimbursement Est. 1991
Grant Federal Active

NSERC Idea to Innovation (I2I) Grants

Natural Sciences and Engineering Research Council of Canada (NSERC)
Maximum Funding
Phase I up to $125,000 (100%); Phase...
Quarterly intakes: Jun 22, 2026; Sep 21, 2026
Visit Official Program →
Difficulty
Hard
Payment
Reimbursement
Trend
Stable
First-Timers
Co-Funding
100%
NSERC Idea to Innovation (I2I) Grants provides up to Phase I up to $125,000 (100%); Phase IIa up to $125,000/yr (67%); Phase IIb up to $350,000 over 2 years (50%). Funds university and college researchers to advance promising technologies from proof-of-concept toward commercial use, with Phase IIb engaging a Canadian company partner to co-fund development. Quarterly intakes: Jun 22, 2026; Sep 21, 2026. (As of May 2026, verified against Natural Sciences and Engineering Research Council of Canada (NSERC) program guidelines)

Eligibility & Details

What this program funds and who can apply

Free

Program Description

Funds university and college researchers to advance promising technologies from proof-of-concept toward commercial use, with Phase IIb engaging a Canadian company partner to co-fund development. The program covers up to 100% of Phase I costs and 50% of Phase IIb costs, giving SMEs a direct pathway to license emerging academic IP.

Eligibility Requirements

  • College or university researcher/faculty with promising technology at TRL 4 or higher
  • Institution must be declared eligible by NSERC to administer grants
  • Phase IIb requires a Canadian company partner with at least 50% matching (minimum 40% in cash); foreign companies considered if clear Canadian economic benefit
  • IP must be managed by the institution's ILO with a commercialization strategy
  • Phases I + II combined limited to 3 years per technology
  • Companies cannot apply directly — must partner with an eligible researcher/institution
Provinces
Industries
Business Stage
Growth Expansion

Quick Assessment

Difficulty
Hard
Competition
Moderate
Est. Hours
60h
First-Timer
Not rated

Funding Details

Amount
Phase I up to $125,000 (100%); Phase IIa up to $125,000/yr (67%); Phase IIb up to $350,000 over 2 years (50%)
Type
Grant
Level
Federal
Co-Funding
Up to 100% of eligible costs
Deadline
Quarterly intakes: Jun 22, 2026; Sep 21, 2026

Program Scorecard

Competition, effort, and approval at a glance

Hybrid
Competition
Moderate
Effort
~60 hours
Approval
Varies
Accessibility
--/5
Competition
--/5
Approval Rate
--%
Premium See how this program compares on approval odds, difficulty, and competition — so you know if it’s worth your time.
Know your real odds before investing 40+ hours
Approval likelihood, realistic amounts, competition level, and what winners look like
Consultants charge $500–$2,000 per program. This Playbook is $19.
What's in this Playbook

Everything you need to win I2I — $19

Not a marketing summary. The actual checklist, intel, and stack strategy reviewers look for.

Consultants charge $2,000–$5,000 per program. This Playbook is $19. Yours forever.

Applying for I2I? Our Financial Projections Model ($29) covers the multi-year projections and burn-rate math reviewers look for. Or get all 4 templates in the Founder Pack ($59 · saves $27) →

How to Win

Insider tips, common pitfalls, and what successful applicants look like

Premium
Insider Tip

Companies cannot apply directly — engage a university or college researcher first. The ILO at the institution is your key contact; they co-develop the application with the researcher. For Phase IIb, negotiate the IP licensing/option agreement before the intake deadline — NSERC requires it at submission. Target technologies at TRL 4–6 (basic parameters validated, moving to prototype). Phase Ia is a stepping stone — budget for the 2-year Phase IIb journey from the start.

Premium See what trips up most applicants for this program — and how to avoid it.

Rejection Pitfalls 6

  • Technology not at minimum TRL 4 — insufficient experimental validation
  • No credible commercialization plan or market pathway identified
  • IP not managed by the institution's ILO — alternative IP arrangements not acceptable
+3 more pitfalls
Premium See the most common reasons applications get rejected — before you submit yours.

Success Profile

A university or college researcher who has developed novel technology at TRL 4–5 and has identified a Canadian SME willing to co-invest in the commercialization phase. The ideal company partner has 10–200 employees, existing manufacturing or distribution capability, and a clear market pathway for the licensed technology.

Premium See what successful applicants for this program actually look like.

Evaluation Criteria

Applications are reviewed by the I2I committee (business and investment expertise) and external technical reviewers. Key criteria: (1) scientific and technical merit and feasibility of achieving TRL advancement, (2) team expertise including industry liaison experience, (3) technology transfer potential and commercial benefit to Canada, (4) quality of market analysis and partner commitment. Phase IIb additionally assessed on strength of the partnership, business plan, and company's capacity to manufacture and distribute the resulting product.

Premium See exactly what reviewers score on — so you know where to focus.
Don’t waste 60 hours on a preventable rejection
6 reasons applications get rejected, what winners look like, and exactly what reviewers score on
Paid grant writers quote $2,000–$5,000 per program. Start with the $19 Playbook first.

Application Playbook

Step-by-step process, required documents, and expenses

Premium 6 steps 9 docs

Application Steps

1 Identify Your Institution's ILO Contact your university or college's Industry Liaison Office (ILO) or Technology Transfer Office. They co-develop the application with the researcher and must be identified at the outset. If you are a company, approach a researcher first, then engage their ILO.
2 Validate Technology Readiness Confirm the technology is at TRL 4 or higher — basic parameters must be explored with sufficient testing demonstrating innovation potential in a real-world environment. Gather existing experimental data and IP documentation.
3 Negotiate Partnership Agreement (Phase II) For Phase IIb, negotiate and finalize an IP licensing or option agreement between the institution and the company partner before the intake deadline. The company must commit to providing at least 50% of total project costs (minimum 40% in cash).
4 Prepare Application Package Complete NSERC Form 100A, Form 101, and Form 183A (Phase II). Prepare a detailed technical project plan, technology transfer plan, budget, and commercialization pathway. Include go/no-go decision milestones.
5 Submit via NSERC Online Portal Submit through the NSERC online system by the quarterly intake deadline (January, March, June, or September). Note: Market Assessment and Phase Ib supplement intakes remain paused as of May 2026.
6 Committee Review I2I committee and external technical reviewers assess applications. Decision timeline is typically 8–16 weeks post-intake close.

Required Documents 9

NSERC Form 100A (Personal data for all applicants and co-investigators)
NSERC Form 101 (Application for a grant)
NSERC Form 183A (Phase II partnership information — Phase II only)
Detailed research/technical project plan with milestones and go/no-go decision points
Budget breakdown by cost category
Technology transfer plan with market validation and commercialization pathway
IP licensing or option agreement between institution and company partner (Phase II only)
Proof of partner financial commitment (Phase IIb — letter, financial statements)
Company profile demonstrating manufacturing/distribution capacity (Phase IIb)

Eligible Expenses 6

  • Salaries and benefits for research staff conducting technology refinement and prototype work
  • Materials, supplies, and small equipment required for the project
  • Subcontractor fees for specialized technical work
  • Technology transfer activities up to 10% of total award (market research, patent preparation, business planning, mentoring fees)
  • Travel directly related to project objectives (partner visits, field studies)
  • Project management costs up to 10% of direct costs (Phase IIb only)

Ineligible Expenses 7

  • Applicant's own salary or consulting fees
  • Overhead and indirect costs (covered by institution)
  • Conference attendance and academic publications (unless directly serving commercialization objectives)
  • Capital equipment unrelated to the technology being transferred
  • General operating expenses of the institution or company
  • Marketing and sales activities
  • Release from teaching (replacement faculty salaries) for the grantee

Intake Periods

Quarterly: January, March, June, September. Market Assessment and Phase Ib supplement intakes paused since February 14, 2025. Phase Ia, IIa, and IIb remain open. Next 2026 intakes: June 22 and September 21.

Deadline Notes

Four annual intakes: January, March, June, September. Market Assessment and Phase Ib supplement intakes paused since February 14, 2025. Phase Ia, IIa, and IIb remain active. Apply through your institution's Industry Liaison Office (ILO) — companies cannot apply directly. Allow 4–8 weeks for ILO preparation before the intake deadline.

Open Application Portal →

Ineligible Organizations

  • Companies applying directly without an academic researcher/institution partner
  • Researchers at institutions not declared eligible by NSERC
  • Non-Canadian entities (unless clear Canadian economic benefit demonstrated for Phase IIb)
Premium Get the step-by-step application guide — documents, timeline, and what to prepare.

Funding Stack Strategy

Compatible programs, clawback risk, and combined funding potential

Premium 3 partners

Compatible Programs

NRC IRAP SR&ED Tax Credit Mitacs Accelerate
Combined Funding Potential See your total funding potential

Clawback Risk

Low Risk

Low risk. Phase IIb milestone failures may result in discontinued future tranches; completed-phase disbursements are not typically recovered.

Premium See which programs combine with this one — and how much more you could get.
See your total funding potential across 3 programs
Stacking amounts, clawback details, government stacking limits, and tax implications
One avoided clawback typically outweighs the $19 Playbook cost by 50–100×.

How I2I Compares

Side-by-side with similar programs

Free
Program Amount Difficulty Payment Deadline
NSERC Idea to Innovation (I2I) Grants up to $125,000 Hard Reimbursement Quarterly intakes: Jun...
NRC IRAP Clean Technology Program $100,000–$500,000 Hard Mixed (Advance + Reimb.) Ongoing
Mitacs Accelerate $15,000 per internship unit Easy Advance Payment Ongoing
Strategic Response Fund (formerly Str... Up to $50 million Hard Mixed (Advance + Reimb.) Ongoing — continuous...
CanExport SMEs Up to $50,000 Moderate Mixed (Advance + Reimb.) Next deadline: May 29,...

Related Programs

Other programs you might be eligible for

Free

Frequently Asked Questions

Quick answers to the questions founders most often ask about I2I

Free
Can my company apply directly for an I2I grant?
No. Only university or college researchers can apply directly. Your company must partner with an eligible researcher and their institution's ILO. The researcher and ILO co-develop the application.
What is Phase IIb and what does the company contribute?
Phase IIb is the commercialization phase where a Canadian company co-invests alongside NSERC. NSERC covers up to 50% of eligible project costs (max $350,000); the company must provide at least 50% (minimum 40% in cash). A signed IP licensing or option agreement is required at submission.
Is Market Assessment or Phase Ib available in 2026?
No. NSERC paused intake for Market Assessment projects and Phase Ib supplements as of February 14, 2025, for program review. Phase Ia, IIa, and IIb remain open with quarterly intakes.
What technology readiness level is required?
Minimum TRL 4 for Phase I — basic parameters must be explored with sufficient testing demonstrating innovation potential. Phase II requires demonstrated achievement of prior phase objectives, typically TRL 5–6.

Browse More Funding